2018-06-11T08:46:32-05:00 2017-09-30 050255779 SANSIVERI KIMBALL & CO LLP 50 HOLDEN STREET PROVIDENCE RI 02908 990 2016-10-01 050317817 RHODE ISLAND BLOOD CENTER RHOD 4014538360 405 PROMENADE STREET PROVIDENCE RI 02908 KENNETH ALLEN CHIEF FINANCIAL OFFICER 4014538519 2018-06-07 1 ELIZABETH RESENDES CPA P00533754 4013310500 2018-06-07 2016 2022-09-23 18:48:47Z LAWRENCE SMITH 405 PROMENADE STREET PROVIDENCE RI 02908 47561687 0 X WWW.RIBC.ORG X 1979 RI COLLECTION, TESTING & DISTRIB. OF BLOOD & BLOOD PRODUCTS FOR HOSPITALS IN RI & OTHER STATES. 7 4 371 96 0 0 4898 8065 40202793 43974729 663736 220527 105760 105760 40977187 44309081 0 0 0 0 18022117 18831831 0 0 0 22812255 26188519 40834372 45020350 142815 -711269 38990338 38935670 12689896 12935358 26300442 26000312 THE RHODE ISLAND BLOOD CENTER COLLECTS, TESTS, AND DISTRIBUTES BLOOD AND BLOOD PRODUCTS FOR HOSPITALS IN RHODE ISLAND WHILE ALSO SERVING CUSTOMERS IN VARIOUS STATES, PRINCIPALLY IN NEW ENGLAND. 0 0 38411959 44080489 COLLECTION, TESTING, AND DISTRIBUTION OF BLOOD AND BLOOD PRODUCTS FOR HOSPITALS IN RHODE ISLAND WHILE ALSO SERVING CUSTOMERS IN VARIOUS STATES, PRINCIPALLY IN NEW ENGLAND. 38411959 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 1 12 0 1 371 1 0 0 0 0 0 0 0 0 0 0 X 7 4 1 0 1 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 RI X KENNETH ALLEN CFO 4014538519 405 PROMENADE STREET PROVIDENCE RI 02908 LAWRENCE F SMITH CEO 40.00 X X 341804 0 31127 CHRISTOPHER D HILLYER MD PRESIDENT 2.00 56.00 X X 0 1568412 97141 THOMAS HEANEY TRUSTEE 1.00 1.00 X 0 0 0 DAVID TENDLER TRUSTEE 1.00 8.00 X 0 0 0 MARK SCHMIDTLEIN TRUSTEE 1.00 4.00 X 0 0 0 CHARLES R REPPUCCI TRUSTEE, SECRETARY 1.00 2.00 X X 0 0 0 MARK A SHAW TRUSTEE, TREASURER 1.00 1.00 X X 0 0 0 R STEPHEN MANTY CPA TRUSTEE, TREASURER-RESIGNED 6/30/17 0.20 X X 0 0 0 WILLIAM P MCGILLIVRAY CPA TRUSTEE-RESIGNED 12/31/16 0.20 X 0 0 0 DARIUSZ STACHURSKI MD TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 NICHOLAS P DOMINICK JR TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 STEPHEN J CARLOTTI TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 SANDRA L COLETTA TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 SAMUEL CIOTOLA TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 JOSEPH SWEENEY MD TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 JAMES MONIZ JR CPA TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 ALAN M LOTVIN MD TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 KIMBERLY O'CONNELL TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 CHRISTOPHER M LEHRACH MD MBA TRUSTEE-RESIGNED 6/30/17 0.20 X 0 0 0 KENNETH N ALLEN JR CHIEF FINANCIAL OFFICER 40.00 X 176423 0 27036 CAROLYN T YOUNG MD VP & CHIEF MEDICAL OFCR 40.00 X 277594 0 31234 SCOTT J ASADORIAN VP & CHIEF OPER OFFICER 40.00 X 233175 0 21301 DARLENE FOLAN VP QUALITY ASSURANCE 40.00 X 154196 0 25837 PATRICIA LANG DIR. PATIENT & CELL THERAP 40.00 X 120406 0 23954 PAUL FOURNIER DIRECTOR OF ACCOUNTING 40.00 X 111072 0 22170 JILL ALBERIGO DIRECTOR OF DONOR SERVICES 40.00 X 114790 0 23794 KATHRYN E MANCHESTER DIRECTOR OF IT 40.00 X 150296 0 15671 DAVID REYNOLDS SYSTEMS NETWORK MANAGER 40.00 X 113428 0 23426 1793184 1568412 342691 13 0 1 0 HINCKLEY ALLEN 100 WESTMINSTER ST 1500 PROVIDENCE RI 02903 LEGAL 284528 1 8065 8065 SALES-BLOOD/COMPONENTS 621500 34653775 34653775 LABORATORY & TEST SVCS 621500 8530011 8530011 RECOVERED PLASMA 621500 755948 755948 34995 34995 43974729 199044 199044 130160 24400 105760 105760 105760 3249689 3228206 21483 21483 21483 44309081 44080489 0 220527 1619805 259115 1360690 13377387 11731954 1645433 423551 370341 53210 2366840 1918047 448793 1044248 865707 178541 311433 311433 45100 45100 9000 9000 590687 323937 266750 392748 392748 585875 408236 177639 340664 173858 166806 1066950 406236 660714 487631 457000 30631 60702 15325 45377 330189 330189 1162404 541223 621181 316536 316536 PRODUCTION 18953964 18936071 17893 SHIPPING 956923 861334 95589 EQUIP/FURN RENTAL/MAINT 283838 220646 63192 DUES AND FEES 213294 119411 93883 80581 80581 45020350 38411959 6608391 0 2407837 2604111 5746947 6219824 1435200 1931848 471918 483558 28497728 11954213 16286732 16543515 11732653 11152814 909051 0 38990338 38935670 3797658 4278055 8044095 7848428 48875 40375 799268 768500 12689896 12935358 X 26300442 26000312 26300442 26000312 38990338 38935670 -711269 411139 0 X X 0 1 X 1 0 X 191020 104000 15550 4898 8065 323533 44003911 42047341 38760980 40202791 43974723 208989746 44194931 42151341 38776530 40207689 43982788 209313279 0 0 0 209313279 176760 189993 172830 324502 329204 1193289 176760 189993 172830 324502 329204 1193289 44371691 42341334 38949360 40532191 44311992 210506568 0.99430 0.99500 0.00570 0.00500 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 0 0 1 9000 9000 0 PART II-B, LINE 1: IN 2016, RHODE ISLAND BLOOD CENTER UTILIZED A LOBBYIST TO MONITOR LEGISLATION ACTIVITY. 2443991 2443991 15635542 4464561 11170981 9666305 6971821 2694484 751890 517831 234059 16543515 RELATED PARTY ADVANCE-NYBC 768500 768500 X 44720220 411139 411139 44309081 0 44309081 45020350 0 45020350 0 45020350 PART X, LINE 2: RIBC EVALUATES ALL SIGNIFICANT TAX POSITIONS. AS OF SEPTEMBER 30, 2017, RIBC DOES NOT BELIEVE THAT THEY HAVE TAKEN ANY TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF ANY TAX LIABILITY NOR DOES IT BELIEVE THAT THERE ARE ANY UNREALIZED TAX BENEFITS THAT WOULD EITHER INCREASE OR DECREASE WITHIN THE NEXT TWELVE MONTHS. RIBC'S INCOME TAX RETURNS ARE SUBJECT TO EXAMINATION BY THE APPROPRIATE TAXING JURISDICTIONS. AS OF SEPTEMBER 30, 2017, RIBC'S INCOME TAX RETURNS GENERALLY REMAIN OPEN FOR EXAMINATION FOR THREE YEARS FROM THE DATE FILED WITH EACH TAXING JURISDICTION. X X X X X X 0 1 0 0 0 0 0 0 0 LAWRENCE F SMITH CEO 341804 0 0 0 0 0 13000 0 18127 0 372931 0 0 0 CHRISTOPHER D HILLYER MD PRESIDENT 0 944412 0 600000 0 24000 0 66500 0 30641 0 1665553 0 0 KENNETH N ALLEN JR CHIEF FINANCIAL OFFICER 176423 0 0 0 0 0 9132 0 17904 0 203459 0 0 0 CAROLYN T YOUNG MD VP & CHIEF MEDICAL OFCR 277594 0 0 0 0 0 13000 0 18234 0 308828 0 0 0 SCOTT J ASADORIAN VP & CHIEF OPER OFFICER 233175 0 0 0 0 0 13000 0 8301 0 254476 0 0 0 DARLENE FOLAN VP QUALITY ASSURANCE 154196 0 0 0 0 0 8025 0 17812 0 180033 0 0 0 KATHRYN E MANCHESTER DIRECTOR OF IT 150296 0 0 0 0 0 7678 0 7993 0 165967 0 0 0 PART I, LINE 4B LAWRENCE F. SMITH (CEO) PARTICIPATED IN A SERP THROUGH JUNE 30, 2017, AT WHICH TIME THE PLAN ENDED PURSUANT TO THE TRANSACTION WITH NEW YORK BLOOD CENTER, INC., AS MORE FULLY DESCRIBED ON SCHEDULE O. NO PAYMENTS WERE MADE TO MR. SMITH FOR CALENDAR YEAR 2016, WHICH ENDED WITHIN THE ORGANIZATION'S TAX YEAR REPORTED HEREIN. A RHODE ISLAND HEALTH AND EDUCATIONAL BUILDING CORPORATION 521300173 2012-06-29 9000000 CONSTRUCTION OF AN ADDITION & RENOVATION OF FACILITIES. 0 0 0 A 9000000 98450 8497647 403903 2014 0 0 1 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 0 A 0 0 1 0 0 0 0 0 1 A 0 SCHEDULE K, PART I, BOND ISSUES PROCEEDS FROM THE BOND WERE BE USED TO FINANCE THE ACQUISITION, CONSTRUCTION, EQUIPPING AND FURNISHING OF A 20,000 SQUARE FOOT ADDITION ADJACENT TO THE MAIN FACILITY. THE ADDITION HOUSES THE ORGANIZATION'S OPERATIONAL REGULATORY FUNCTIONS, INCLUDING LABORATORIES AND DISTRIBUTION FUNCTIONS. IN ADDITION, RENOVATIONS AND IMPROVEMENTS WERE MADE TO THE ORGANIZATION'S MAIN FACILITY LOCATED AT 405 PROMENADE ST, PROVIDENCE, RI. SCHEDULE K, PART II, LINE 11 THE PROCEEDS FROM THE BOND ISSUE WERE PROVIDED IN THE FORM OF A DRAW DOWN FACILITY FROM WHICH PROCEEDS COULD BE DRAWN DOWN UNTIL MARCH 29, 2014. ALL AMOUNTS DRAWN WERE USED FOR CAPITAL EXPENDITURES AND BOND ISSUANCE COSTS IN THE AMOUNTS AS DESCRIBED ABOVE. ON MARCH 29, 2014, THE DRAW DOWN FACILITY CONVERTED TO A LOAN PAYABLE REQUIRING PRINCIPAL AND INTEREST PAYMENTS. AT THE CONVERSION DATE, THE TOTAL OUTSTANDING BORROWINGS AMOUNTED TO $8,596,097. A PREPAYMENT WAS MADE ON THE BOND FOR THE BALANCE OF THE BOND ISSUE, $403,903. JAMES MONIZ JR CPA TRUSTEE 299808 INSURANCE PREMIUMS 0 WILLIAM P MCGILLIVRAY CPA TRUSTEE 299808 INSURANCE PREMIUMS 0 CHARLES R REPPUCCI TRUSTEE, FAMILY MEMBER 49013 EMPLOYEE COMPENSATION 0 FORM 990, PART VI, SECTION A, LINE 1 LINE 1A EXCEPT AS PROVIDED BY APPLICABLE STATE LAW, THE ARTICLES OF INCORPORATION OF THE ORGANIZATION, OR BY FURTHER RESOLUTION OF A MAJORITY OF THE BOARD, THE ORGANIZATION'S EXECUTIVE COMMITTEE MAY EXERCISE THE FULL AUTHORITY OF THE BOARD, AS NEEDED, BETWEEN MEETINGS OF THE BOARD. SUCH EXECUTIVE COMMITTEE IS COMPOSED OF THE CHAIRPERSON AND VICE-CHAIRPERSON OF THE BOARD, THE PRESIDENT AND FIVE OTHER TRUSTEES OF THE ORGANIZATION. IN THE EVENT THAT ANY MEMBER OF THE EXECUTIVE COMMITTEE CEASES TO BE A TRUSTEE OF THE ORGANIZATION, HIS OR HER POSITION ON THE EXECUTIVE COMMITTEE SHALL BE DEEMED VACANT AND SHALL BE FILLED IN ACCORDANCE WITH THE BY-LAWS OF THE ORGANIZATION. EFFECTIVE JUNE 30, 2017, ALL MEMBERS OF THE BOARD RESIGNED PURSUANT TO THE MEMBERSHIP TRANSACTION AGREEMENT DESCRIBED BELOW, AND A NEWLY ELECTED BOARD WAS APPOINTED. FORM 990, PART VI, SECTION A, LINE 2 CHARLES REPPUCCI AND STEPHEN CARLOTTI HAVE A BUSINESS RELATIONSHIP THROUGH HINCKLEY, ALLEN & SNYDER LLP. NICHOLAS DOMINICK AND JOSEPH SWEENEY HAVE A BUSINESS RELATIONSHIP THROUGH LIFESPAN CORPORATION AND/OR ORGANIZATIONS THAT ARE ULTIMATELY CONTROLLED BY LIFESPAN CORPORATION. CHARLES REPPUCCI AND SANDRA COLETTA HAVE A BUSINESS RELATIONSHIP THROUGH CARE NEW ENGLAND AND/OR AN ORGANIZATION THAT IS ULTIMATELY CONTROLLED BY CARE NEW ENGLAND. LAWRENCE SMITH IS A MEMBER OF THE GOVERNING BODY OF BLOOD CENTERS OF AMERICA. EFFECTIVE JUNE 30, 2017, ALL MEMBERS OF THE BOARD RESIGNED PURSUANT TO THE MEMBERSHIP TRANSACTION AGREEMENT DESCRIBED BELOW, AND A NEWLY ELECTED BOARD WAS APPOINTED. CHARLES REPPUCCI IS A MEMBER OF THE NEWLY ELECTED BOARD. MARK SCHMIDTLEIN, CHRISTOPHER HILLYER, DAVID TENDLER AND CHARLES REPUCCI HAVE A BUSINESS RELATIONSHIP THROUGH NEW YORK BLOOD CENTER, INC. FORM 990, PART VI, SECTION A, LINE 4 EFFECTIVE JUNE 30, 2017, RHODE ISLAND BLOOD CENTER (RIBC) EXECUTED A MEMBERSHIP TRANSACTION AGREEMENT (THE AGREEMENT) WITH NEW YORK BLOOD CENTER, INC. (NYBC), A NEW YORK NOT-FOR-PROFIT CORPORATION, UNDER WHICH NYBC BECAME THE SOLE MEMBER OF RIBC. NO CASH CONSIDERATION WAS TRANSFERRED FOR THE NET ASSETS OF RIBC. RIBC SHALL FUNCTION AS AN INTEGRATED PART OF THE NETWORK OF BLOOD, BLOOD SERVICES AND TRANSFUSION MEDICINE OF THE SOLE MEMBER OF THE ORGANIZATION, NYBC, AND SHALL SUPPORT, AND CARRY OUT THE PURPOSES OF THE ORGANIZATION IN COORDINATION WITH THE CORRESPONDING SERVICES OF NYBC AND OTHER NOT-FOR-PROFIT BLOOD, BLOOD SERVICES AND TRANSFUSION MEDICINE ORGANIZATIONS OF WHICH NYBC IS THE SOLE MEMBER. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS A SOLE MEMBER EFFECTIVE JUNE 30, 2017, PURSUANT TO THE MEMBERSHIP TRANSACTION AGREEMENT DESCRIBED ABOVE. FORM 990, PART VI, SECTION A, LINE 7A BOARD TRUSTEES THAT ARE "HOSPITAL DESIGNEES," DISTINGUISHED FROM TRUSTEES AT LARGE, ARE APPOINTED BY NON-GOVERNMENTAL HOSPITALS LICENSED IN THE STATE OF RHODE ISLAND THAT UTILIZE BLOOD BANKING SERVICES. PERSONS DESIGNATED TO SERVE AS HOSPITAL DESIGNEES OF THE ORGANIZATION SHALL BE EITHER EMPLOYEES OF THE DESIGNATING HOSPITAL OR MEMBERS OF THE GOVERNING BODY OF THE DESIGNATING HOSPITAL. EACH HOSPITAL DESIGNEE SERVES ON THE BOARD FOR ONE YEAR OR UNTIL A SUCCESSOR IS DESIGNATED AND HAS QUALIFIED. TRUSTEES AT LARGE ARE APPOINTED BY THE BOARD. THE NUMBER OF SUCH HOSPITAL DESIGNEES AND THE NUMBER OF OTHER BOARD MEMBERS SHALL BE AS NEARLY EQUAL IN NUMBER AS POSSIBLE; PROVIDED, THAT THE NUMBER OF TRUSTEES AT LARGE SHALL NOT EXCEED THE AGGREGATE NUMBER OF HOSPITAL DESIGNEES. EFFECTIVE JUNE 30, 2017, ALL MEMBERS OF THE BOARD RESIGNED PURSUANT TO THE MEMBERSHIP TRANSACTION AGREEMENT DESCRIBED ABOVE, AND A NEWLY ELECTED BOARD WAS APPOINTED. NO "HOSPITAL DESIGNEES" WERE APPOINTED TO THE NEW BOARD. THE SOLE MEMBER HAS THE RIGHT TO ELECT ALL OF THE MEMBERS OF THE RIBC BOARD. FORM 990, PART VI, SECTION A, LINE 7B EFFECTIVE JUNE 30, 2017, GOVERNANCE DECISIONS OF THE ORGANIZATION ARE SUBJECT TO APPROVAL BY THE SOLE MEMBER OF THE ORGANIZATION, NYBC, AS DESCRIBED ABOVE. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS DISTRIBUTED TO THE BOARD OF TRUSTEES OF THE ORGANIZATION PRIOR TO FILING. IN ADDITION, THE FORM 990 IS REVIEWED AND APPROVED BY THE ORGANIZATION'S AUDIT COMMITTEE AS APPOINTED BY NYBC. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION ANNUALLY DISTRIBUTES A CONFLICT OF INTEREST DISCLOSURE QUESTIONNAIRE TO ALL BOARD MEMBERS, OFFICERS, AND HIGH-LEVEL EMPLOYEES. A DESCRIPTION OF VARIOUS TYPES OF POTENTIAL CONFLICTS IS GIVEN AND RECIPIENTS ARE ASKED TO DISCLOSE FINANCIAL, PROFESSIONAL, AND PERSONAL CONFLICTS, IF ANY. DISCLOSURES MADE BY RECIPIENTS ARE REVIEWED BY MANAGEMENT, INCLUDING THE BOARD AND OUTSIDE COUNSEL, AS NEEDED. WHEN APPROPRIATE, THE BOARD MAY TAKE FURTHER ACTION TO ADDRESS THE CONFLICT, SUCH AS PROHIBITING A PERSON WITH A CONFLICT FROM VOTING ON CERTAIN ISSUES, OR OTHER APPROPRIATE MEASURES DEEMED NECESSARY TO PROTECT THE BEST INTERESTS OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD APPOINTS A COMPENSATION COMMITTEE COMPRISED OF THREE TO FIVE TRUSTEES, NONE OF WHOM HAVE AN UNDISCLOSED CONFLICT OF INTEREST WITH RESPECT TO THE DISCHARGE OF THEIR DUTIES ON BEHALF OF THE COMPENSATION COMMITTEE. IN THE EVENT THAT ANY MEMBER OF THE COMPENSATION COMMITTEE CEASES TO BE A TRUSTEE, HIS OR HER POSITION ON THE COMPENSATION COMMITTEE SHALL BE DEEMED VACANT AND SHALL BE FILLED IN ACCORDANCE WITH THE BY-LAWS OF THE ORGANIZATION. THE COMPENSATION COMMITTEE'S DUTIES INCLUDE PERIODICALLY REVIEWING THE ORGANIZATION'S EXECUTIVE COMPENSATION PHILOSOPHY AND PLAN AND MAKING RECOMMENDATIONS AS APPROPRIATE, ANNUALLY RECOMMENDING WRITTEN PERFORMANCE GOALS AND OBJECTIVES FOR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, ANNUALLY CONDUCTING A WRITTEN PERFORMANCE REVIEW OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, ANNUALLY ESTABLISHING THE PRESIDENT AND CHIEF EXECUTIVE OFFICER'S COMPENSATION (INCLUDING PERFORMANCE OR OTHER BONUSES, IF ANY), AND ANNUALLY APPROVING THE COMPENSATION OF OTHER KEY EXECUTIVES. THE COMPENSATION OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER SHALL BE BASED ON A WRITTEN REVIEW OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER'S PERFORMANCE, THE ORGANIZATION'S EXECUTIVE COMPENSATION PLAN, A RECENT SALARY SURVEY OF POSITIONS COMPARABLE TO THAT OF THE ORGANIZATION'S PRESIDENT AND CHIEF EXECUTIVE OFFICER, AND SUCH OTHER FACTORS AS THE COMPENSATION COMMITTEE DETERMINES TO BE IN THE ORGANIZATION'S INTEREST. IN ADDITION, THE COMPENSATION COMMITTEE REGULARLY ENGAGES A COMPENSATION CONSULTANT TO PROVIDE ADVICE REGARDING THE COMPENSATION OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE COMPENSATION COMMITTEE SHALL PROVIDE TO THE BOARD A REPORT DETAILING THE COMPENSATION (INCLUDING PERFORMANCE AND OTHER BONUSES, IF ANY) SET FOR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER AND THE REASONS THEREFOR. THE COMPENSATION COMMITTEE ALSO REVIEWS AND APPROVES PRESIDENT AND CHIEF EXECUTIVE OFFICER SALARY RECOMMENDATIONS FOR THE POSITIONS OF (I) VICE PRESIDENT AND CHIEF OPERATING OFFICER; (II) CHIEF FINANCIAL OFFICER; AND (III) VICE PRESIDENT AND CHIEF MEDICAL OFFICER OF THE ORGANIZATION. OTHER DUTIES OF THE COMPENSATION COMMITTEE INCLUDE REVIEW AND APPROVAL THE OVERALL COMPENSATION POLICY INCLUDING THE BONUS PLANS OF THE ORGANIZATION AND PROVISION OF OVERSIGHT REGARDING ALL RETIREMENT AND PENSION PLANS CURRENTLY IN PLACE AND WHICH MAY BE IN PLACE FROM TIME TO TIME. EFFECTIVE JUNE 30, 2017, ALL MEMBERS OF THE BOARD, INCLUDING THE COMPENSATION COMMITTEE, RESIGNED PURSUANT TO THE MEMBERSHIP TRANSACTION AGREEMENT DESCRIBED ABOVE, AND A NEWLY ELECTED BOARD WAS APPOINTED. COMPENSATION WILL THEREAFTER BE REVIEWED BY A PROCESS AS DETERMINED BY NYBC, THE ORGANIZATION'S SOLE MEMBER. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC WHERE REQUIRED BY APPLICABLE LAW AND WHEN DEEMED APPROPRIATE BY THE ORGANIZATION. FORM 990, PART XII, ITEM 2C EFFECTIVE JUNE 30, 2017, ALL MEMBERS OF THE BOARD RESIGNED PURSUANT TO THE MEMBERSHIP TRANSACTION AGREEMENT WITH NYBC AS DESCRIBED ABOVE, AND A NEWLY ELECTED BOARD WAS APPOINTED. THE AUDIT COMMITTEE AS APPOINTED BY NYBC IS RESPONSIBLE FOR THE REVIEW OF AUDITED FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT CERTIFIED PUBLIC ACCOUNTANT. NEW YORK BLOOD CENTER INC 310 E 67TH STREET NEW YORK NY 10065 131949477 BLOOD CENTER NY 501(C)(3) LINE 10 N/A 0 COMMUNITY BLOOD CENTER OF GREATER KANSAS CITY 4040 MAIN ST KANSAS CITY MO 64111 440616999 BLOOD CENTER MO 501(C)(3) LINE 10 NEW YORK BLOOD CENTER INC 0 INNOVATIVE BLOOD RESOURCES 737 PELHAM BLVD ST PAUL MN 55114 410693869 BLOOD CENTER MN 501(C)(3) LINE 10 NEW YORK BLOOD CENTER INC 0 BLOOD BANK OF DELMARVA INC 100 HYGEIA DRIVE NEWARK DE 19713 510078596 BLOOD CENTER DE 501(C)(3) LINE 10 NEW YORK BLOOD CENTER INC 0 0 0 0 0 1 0 1 1 0 0 0 1 1 0 0 0 0 0 0